Effect of Banning Menthol Flavorant on Cigarette and E-Cigarette Use
Completed · Not applicable
Conditions studied: Tobacco Use Disorder
In brief
In this pilot study, menthol cigarette smokers will be randomized to one of three experimental marketplaces: 1) a condition simulating a ban on menthol cigarettes but not menthol e-cigarettes (condition A); 2) a condition simulating a ban on both menthol cigarettes and menthol e-cigarettes (Condition B); and 3) a condition in which menthol is not banned for either product (Condition C - the control condition). All conditions would have medicinal nicotine available if subjects decide to quit tobacco products entirely. At visits occurring every two weeks over a 6 week period, subjects will receive "credits" that they could exchange for any product available in their randomized marketplace condition. Outcomes include the amount of each tobacco product used.
Key facts
- Study ID
- NCT03402243
- Run by
- University of Minnesota
- People needed
- 47
- Starts
- 2018-02-26
- Expected to finish
- 2020-03-25
- Last updated by the study team
- 2021-08-10
Who can join
Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Be between the ages of 18 and 64
- Purchase exclusively menthol cigarettes
- Not currently motivated to quit smoking
- Smoking a minimum number of cigarettes per day
You may not qualify if…
- Report a serious, unstable medical or psychiatric condition
- Use any medications that might interfere with measures to be studied (for example, medications known to affect smoking)
- Have used any smoking cessation therapy during the past month
- Regularly use any form of tobacco other than cigarettes
- Are pregnant or breast feeding or planning to become pregnant or breast feed during the study
Where it is running
- Clinical and Translational Sciences Institute — Minneapolis, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.